Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg in Georgia
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Georgia
| Provider | Medicare | Services |
|---|---|---|
| Maxa, Richard M.D. | $0.16 | 13 |
Georgia Pricing in Context
In Georgia, CPT code J7612 (Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg) carries an average Medicare payment of $0.16 — 10% below the national benchmark of $0.17. 9 providers across the state submitted claims for this procedure in 2023, performing 33 total services. Individual payments in GA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Georgia is $4.08, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Georgia sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Georgia lands near $0.52, with self-pay cash prices typically around $1.30. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg cost in Georgia?
The average Medicare payment for Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg in Georgia is $0.16, which is 10% below the national average of $0.17. Providers in GA typically bill $4.08 for this procedure.
What does Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg cost with insurance in Georgia?
With commercial insurance in Georgia, Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg costs an estimated $0.52. Without insurance, the estimated cash price is $1.30. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg in Georgia?
9 providers in Georgia billed Medicare for Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg in 2023, performing 33 total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg cheaper in Georgia than the national average?
Yes — Levalbuterol, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Concentrated Form, 0.5 Mg costs 10% below the national average in Georgia. The state average Medicare payment is $0.16 compared to $0.17 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.